The tablets are the generic equivalent to Endo Pharmaceuticals’ Percocet tablets to treat moderate to moderately severe pain.
The tablet will be manufactured at Watson’s Miami, Florida facility in US.
Headquartered in Corona, US, Watson Pharmaceuticals develops, manufactures and sells proprietary and off-patent pharmaceutical products.